SPR Therapeutics Funding: $650M Raised, M&A

SPR Therapeutics funding overview

SPR Therapeutics is based in Cleveland, Ohio. SPR Therapeutics has raised $650M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a M&A. Investors on record include SLR Capital Partners, Mutual Capital Partners, JumpStart Ventures, NDI Healthcare Fund, Ohio Third Frontier Commission, U.S. Department of Defense. 6 distinct backers are named across the disclosed rounds.

SPR Therapeutics at a glance

Total raised: $650M
Latest round: M&A
Headquarters: Cleveland, Ohio
Notable investors: SLR Capital Partners, Mutual Capital Partners, JumpStart Ventures, NDI Healthcare Fund, Ohio Third Frontier Commission, U.S. Department of Defense

Frequently asked about SPR Therapeutics funding

How much has SPR Therapeutics raised?: SPR Therapeutics has raised $650M in total disclosed funding across the rounds on record.
Who has invested in SPR Therapeutics?: SLR Capital Partners, Mutual Capital Partners, JumpStart Ventures, NDI Healthcare Fund, Ohio Third Frontier Commission, U.S. Department of Defense are named among the investors backing SPR Therapeutics.
What was the latest SPR Therapeutics funding round?: The most recent disclosed round is a M&A.
Where is SPR Therapeutics based?: SPR Therapeutics is based in Cleveland, Ohio.

Totals shown for SPR Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cleveland and the investors behind them below.

SPR Therapeutics Funding: $650M Raised, M&A

SPR Therapeutics funding overview

SPR Therapeutics at a glance

Frequently asked about SPR Therapeutics funding

Companies related to SPR Therapeutics (17)

Browse related funding lists (1)